“…We take advantage of three synergistic, accelerating domains of science—systems biology, metabolic engineering, and synthetic biology—to develop a workflow that reconciles systems-level, multi-omics analysis and genome-scale modeling with synthetic pathway engineering. While the collection of targeted omics data has supported a number of metabolic engineering efforts (Alonso-Gutierrez et al, 2015; George et al, 2014; Han et al, 2001, 2003; Kabir and Shimizu, 2003; Landels et al, 2015; Lee et al, 2005), the extraction of biologically meaningful information from highly dimensional multi-omics data sets remains a continual challenge (Kwok, 2010; Nielsen et al, 2014; Palsson and Zengler, 2010). Engineering strategies such as the design–build–test–analyze (DBTA) cycle (Bailey, 1991) attempt to side-step this issue through rapid iteration and strain assessment, but the “analyze” phase of the cycle is often limited by a narrow focus on one or two experimental outputs such as product titer.…”